Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 12;10(7):1672. doi: 10.3390/biomedicines10071672

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Cell cycle, ploidy, and DNA fragmentation (AP, subG0/G1) represented by propidium iodide stain (PI). Control DNA extrapolate on the PI ax. G0/G1 phase = (A) 95.48%; (B) 2c 59.44%; 4c 10.87%; 8c 6.52%; 16c 12.68%; (C) 0.00%; S phase = (A) 1.27%; (B) 0.00%; (C) 0.00%; G2/M phase = (A) 1.13%; (B) 0.00%; (C) 99.92%; subG0/G1: (A) 1.05%; (B) 3.31%; (C) 0.07%. Legend: AP, cell apoptosis; (A) malignant tumor tissue with an invasion of the prostatic urethra (hyperdiploid, cell cycle arrest in G0/G1 phase); (B) adenoleiomyoma prostate tissue, chronic inflammation hyperplasia (tetrapoliploidy); (C) benign prostatic tissue hyperplasia (aneuploid, present only the G2/M phase).

Cell cycle, ploidy, and DNA fragmentation (AP, subG0/G1) represented by propidium iodide stain (PI). Control DNA extrapolate on the PI ax. G0/G1 phase = (A) 95.48%; (B) 2c 59.44%; 4c 10.87%; 8c 6.52%; 16c 12.68%; (C) 0.00%; S phase = (A) 1.27%; (B) 0.00%; (C) 0.00%; G2/M phase = (A) 1.13%; (B) 0.00%; (C) 99.92%; subG0/G1: (A) 1.05%; (B) 3.31%; (C) 0.07%. Legend: AP, cell apoptosis; (A) malignant tumor tissue with an invasion of the prostatic urethra (hyperdiploid, cell cycle arrest in G0/G1 phase); (B) adenoleiomyoma prostate tissue, chronic inflammation hyperplasia (tetrapoliploidy); (C) benign prostatic tissue hyperplasia (aneuploid, present only the G2/M phase).